Mangalam Drugs & Organics has informed that The Independent Directors at their separate Meeting held on March 30, 2016 at the registered office of the Company, has reviewed the performance of non-independent directors and the Board as a Whole; reviewed the performance of the Chairperson of the Company, taking into account the views of executive directors and non-executive directors; and assessed the quality, quantity and timeliness of flow of Information between the Company management and the Board that is necessary for the Board to effectively and reasonably perform their duties.
The above information is a part of company’s filings submitted to BSE.
